Granite Point Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Granite Point Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,626,667	Closed	-$1.12M	–	228
2020 Q4	$1.12M	Buy	1,626,667 +1,526,667	+1,527%	+$3.25M	0.06%	121
2020 Q3	$225K	Sell	100,000 -800,000	-89%	-$2.28M	0.01%	156
2020 Q2	$3.22M	Buy	900,000 +200,000	+29%	+$722K	0.16%	66
2020 Q1	$2.66M	Sell	700,000 -550,000	-44%	-$1.81M	1.5%	26
2019 Q4	$3.76M	Buy	+1,250,000	New	+$3.25M	0.59%	24

Other funds holding BMY.RT

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return